| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Stuart N. Lane | Q52852517 |
| P2093 | author name string | Ian Seppelt | |
| Anthony McLean | |||
| Anita Shetty | |||
| Eddy Fischer | |||
| Victoria Sadick | |||
| P2860 | cites work | Catastrophic antiphospholipid syndrome: task force report summary. | Q54037099 |
| Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases | Q81811368 | ||
| A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRI | Q85218471 | ||
| Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines | Q22255576 | ||
| Catastrophic antiphospholipid syndrome: a clinical review | Q27009935 | ||
| Rituximab and its therapeutic potential in catastrophic antiphospolipid syndrome | Q27021256 | ||
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients | Q33369688 | ||
| Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group | Q33390678 | ||
| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients | Q33412915 | ||
| Antiphospholipid syndrome; its implication in cardiovascular diseases: a review | Q34331685 | ||
| A rare presentation of primary antiphospholipid syndrome | Q35627251 | ||
| Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases | Q35953379 | ||
| Clinical and laboratory features of the catastrophic antiphospholipid syndrome | Q37340369 | ||
| Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy | Q38108956 | ||
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab | Q38115382 | ||
| Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. | Q38122663 | ||
| Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry | Q38957667 | ||
| Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment. | Q40279074 | ||
| Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin. | Q41929738 | ||
| Long-term treatment of antiphospholipid syndrome with intravenous immunoglobulin in addition to conventional therapy | Q44585678 | ||
| Catastrophic antiphospholipid syndrome - 20 years later | Q46147103 | ||
| Catastrophic antiphospholipid syndrome and pregnancy: an experience of 13 cases | Q46320072 | ||
| Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. | Q50619255 | ||
| Myocardial catastrophe: a case of sudden, severe myocardial dysfunction. | Q53449799 | ||
| P433 | issue | 4 | |
| P921 | main subject | catastrophic antiphospholipid syndrome | Q5051580 |
| P304 | page(s) | 357-364 | |
| P577 | publication date | 2018-03-19 | |
| P1476 | title | Post-partum catastrophic antiphospholipid syndrome presenting with shock and digital ischaemia - A diagnostic and management challenge | |
| P478 | volume | 19 |
Search more.